Literature DB >> 10487691

Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes.

D L Crandall1, E M Quinet, G A Morgan, D E Busler, B McHendry-Rinde, J G Kral.   

Abstract

To further investigate the role of plasminogen activator inhibitor-1 (PAI-1) in adipose tissue physiology, the production and regulation of PAI-1 was determined in primary cultures of human preadipocytes. When expressed as production per cell and cultured under identical conditions, human preadipocytes from both visceral (omental) and sc depots of lean and obese individuals released significant, yet similar, amounts of PAI-1 protein into the conditioned medium. High steady-state PAI-1 messenger RNA (mRNA) concentrations were observed in visceral and sc preadipocytes, with the relative level of expression equivalent to beta-actin mRNA. Tumor necrosis factor alpha significantly decreased PAI-1 production in a concentration-dependent manner in both visceral and sc cultures, whereas transforming growth factor beta significantly elevated PAI-1 production, but only in sc preadipocytes from obese individuals. Addition of insulin had no effect on antigen levels in conditioned medium of preadipocyte cultures. Stimulation of the preadipocyte cultures with a defined medium resulted in differentiation to the adipocyte phenotype, as determined by flow cytometric analysis, verifying the cultures as human preadipocyte. These studies are the first to observe significant PAI-1 mRNA expression and protein production in primary cultures of a human adipose tissue cellular component, and they suggest that nascent adipocytes contribute significantly to the elevated plasma PAI-1 observed in obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487691     DOI: 10.1210/jcem.84.9.5987

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Adipose tissue engineering with cells in engineered matrices.

Authors:  Lauren Flynn; Kimberly A Woodhouse
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

Review 2.  Neurogenic obesity and systemic inflammation following spinal cord injury: A review.

Authors:  Gary J Farkas; David R Gater
Journal:  J Spinal Cord Med       Date:  2017-07-30       Impact factor: 1.985

Review 3.  PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?

Authors:  Mohammad Badran; David Gozal
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

4.  Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients?

Authors:  Min Lou; Magdy Selim
Journal:  Cerebrovasc Dis       Date:  2008-11-22       Impact factor: 2.762

Review 5.  Metabolic complications of obesity.

Authors:  S M Grundy
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

Review 6.  Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.

Authors:  Machteld Sillen; Paul J Declerck
Journal:  Front Cardiovasc Med       Date:  2020-12-22

7.  Glucose starvation and hypoxia, but not the saturated fatty acid palmitic acid or cholesterol, activate the unfolded protein response in 3T3-F442A and 3T3-L1 adipocytes.

Authors:  Adina D Mihai; Martin Schröder
Journal:  Adipocyte       Date:  2015-01-12       Impact factor: 4.534

Review 8.  A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?

Authors:  Machteld Sillen; Paul J Declerck
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

Review 9.  A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.

Authors:  Gael B Morrow; Claire S Whyte; Nicola J Mutch
Journal:  Front Cardiovasc Med       Date:  2021-04-16

10.  Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.

Authors:  Claire S Whyte; Hadj Ahmed Mostefai; Kim M Baeten; Andrew J Lucking; David E Newby; Nuala A Booth; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.